Bispectral index protocol
BehavioralAim to titrate anesthesia to maintain BIS between 40 and 60.
NCT Number: NCT00682825
The overall purpose of this study is to see if a Bispectral Index (BIS) monitor, a Food and Drug Administration (FDA) approved brain monitoring device, will help to reduce the risk of patients remembering being awake during surgery. The BIS monitor may be able to measure how asleep a patient is during surgery. Using the BIS monitor to guide anesthesia will be compared with using the concentration of anesthetic gas to guide anesthesia.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
University of Manitoba, Winnipeg, Manitoba, Canada
The incidence of anesthesia awareness (AA) is 0.1-0.2% and may result in post traumatic stress disorders. For some patients, owing to illness, medications, substance misuse or surgery, the risk approaches 1%. The B-AWARE Study by Myles et al. suggested that the bispectral index (BIS) monitor, which reportedly reflects anesthetic depth, may decrease the incidence of AA in higher risk patients by 82%. The American Society of Anesthesiologists has published a practice advisory on AA, which does not recommend the routine use of cerebral function monitors. We propose to test the hypothesis that an anesthetic protocol based on BIS decreases the incidence of AA among higher risk patients compared with an anesthetic protocol based on the end-tidal anesthetic gas (ETAG) concentration. We have completed a randomized, single-blinded prospective feasibility study (The B-Unaware Trial) which enrolled 2000 patients at higher risk for AA. Four patients (0.21%; 95% CI=0.06% to 0.57%) had definite AA, of whom two were in the BIS-guided group and two in the ETAG-guided group. Nine patients (0.46%; 95% CI=0.22% to 0.91%) had definite or possible AA, of whom six were in the BIS-guided group and three in the ETAG-guided group. The BAG RECALL study will be a multi-center, prospective, single-blinded, randomized study enrolling 6000 patients at higher risk for AA. The BAG RECALL study is adequately powered and rigorously designed to answer with a reasonable degree of scientific probability whether BIS guidance results in clinically relevant reduction in anesthesia awareness among higher risk patients undergoing general anesthesia.
At the University of Michigan, a parallel study will be conducted - Michigan Awareness Control Study, MACS (NCT00689091) - enrolling 30,000 patients to assess whether the BIS monitor decreases the likelihood of anesthesia awareness among all patients undergoing general anesthesia, regardless of their risk profile. The investigators of this study and the BAG-RECALL study have collaborated in designing these studies and are pre-specifying that common outcome measures will be examined collaboratively including data from both studies.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
MUST HAVE:
General Anesthesia with volatile anesthetic
PATIENT CHARACTERISTICS
Major Criteria (Must have any 1 of the following:)
Exclusion criteria
-
Aim to titrate anesthesia to maintain BIS between 40 and 60.
Aim to maintain anesthetic gas between 0.7 and 1.3 MAC equivalents
Time frame: Three years
Time frame: Three years
Time frame: Five years
Time frame: 5 years
Time frame: Three years
Time frame: Four years
Time frame: Three years
Time frame: Three years
Time frame: Four years
Time frame: Three years
Time frame: Three years
Time frame: Three years
Time frame: Three years
Time frame: Three years
Time frame: Three years
Time frame: Three years
Time frame: Three years
Time frame: Three years
Time frame: Three years
Time frame: Three years
Time frame: Three years
Time frame: Three years
Time frame: Three years
Time frame: Three years
Time frame: Three years
Time frame: Three years
Washington University School of Medicine
Other
BAG-RECALL Study: BIS or Anesthesia Gas to Reduce Explicit Recall
Acronym: BAG-RECALL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00281489
Explicit Recall of Intra-Operative Events
St Louis, Missouri, United States
View Trial Details